Title: Oral health and the role of oral nicotine pouches: A harm reduced future for all
Abstract:
With 1.27 billion smokers worldwide and oral diseases affecting 3.7 billion people, this persistent failure represents one of public health’s most devastating and preventable tragedies. Yet within this crisis lies an unexpected breakthrough. Oral nicotine pouches (ONPs) represent a transformative dual intervention, serving as highly effective cessation tools while directly improving oral health outcomes. Unlike combustible cigarettes that release thousands of toxic chemicals or traditional smokeless tobacco laden with carcinogens, ONPs deliver nicotine without combustion, without tobacco leaf and with dramatically reduced harm. More significantly, evidence now demonstrates ONPs may be one of the most effective smoking cessation tool available today, offering smokers a familiar oral experience and satisfying nicotine delivery, as well as being a measurable pathway to better health. This research examines this unique dual role through clinical evidence, population-level success stories and emerging science that validates why the oral health community should embrace ONPs as essential tools to combat tobacco-related disease and to achieve the World Health Organization (WHO)’s Global Strategy on Oral Health (2023–2030).
Low- and middle-income countries (LMICs) bear a disproportionate 84% of this burden, largely driven by smoking and high-risk smokeless tobacco use. Despite decades of tobacco control efforts, current approaches have plateaued in their effectiveness. In terms of access, affordability and consumer acceptance, ONPs offer a uniquely suited intervention for LMIC contexts with minimal infrastructure requirements, shelf-stability and low-cost potential and cultural compatibility with oral product use patterns. ONPs represent a legitimate, effective harm reduction tool capable of delivering measurable improvements in both cessation rates and oral health outcomes, without causing serious health harms. With the oral disease burden rising, cessation rates stagnating and health inequalities widening, risk-proportionate regulation of ONPs represents an essential component of 21st century public health policy. It could save millions of lives and dramatically reduce the global disease burden of oral disease, disability and premature death. This research helps provide the evidence base, policy frameworks and strategic roadmap needed to transform oral health through harm reduction.
